0001903671-25-000002.txt : 20251229 0001903671-25-000002.hdr.sgml : 20251229 20251229153558 ACCESSION NUMBER: 0001903671-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251229 DATE AS OF CHANGE: 20251229 EFFECTIVENESS DATE: 20251229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glycologix, Inc. CENTRAL INDEX KEY: 0001903671 ORGANIZATION NAME: EIN: 871992372 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-568234 FILM NUMBER: 251608916 BUSINESS ADDRESS: STREET 1: 100 CUMMINGS CENTER, SUITE 451C CITY: BEVERLY STATE: MA ZIP: 01915 BUSINESS PHONE: 6174802536 MAIL ADDRESS: STREET 1: 100 CUMMINGS CENTER, SUITE 451C CITY: BEVERLY STATE: MA ZIP: 01915 D 1 primary_doc.xml X0708 D LIVE 0001903671 Glycologix, Inc. 100 CUMMINGS CENTER, SUITE 451C BEVERLY MA MASSACHUSETTS 01915 6174802536 DELAWARE None None Corporation true 2021 Daniel Deardorf 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Executive Officer Director George Adaniya 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Director Michael Chester 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Director Martha Farmer 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Director Michael Marsh 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Director Other Technology No Revenues 06b false 2025-12-12 false true true false 1 1000000 800000 200000 false 30 0 0 250000 true false Glycologix, Inc. Daniel Deardorf Daniel Deardorf Chief Executive Officer 2025-12-29